ACTIGALL

This brand name is authorized in the following countries: United States

Active ingredients

The drug ACTIGALL contains one active pharmaceutical ingredient (API):

UNII 724L30Y2QR - URSODIOL

The ursodeoxycholic acid converts lithogenic bile in non-lithogenic bile and gradually dissolves the cholesterol gallstones.

Read about Ursodeoxycholic acid

Medication package inserts

Below package inserts are available for further reading:

Title
Information Source
Document Type
 
ACTIGALL Capsule
FDA, National Drug Code (US)
Structured Product Labeling (SPL)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
A05AA02
Ursodeoxycholic acid
A Alimentary tract and metabolism → A05 Bile and liver therapy → A05A Bile therapy → A05AA Bile acid preparations
Discover more medicines within A05AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
US
FDA, National Drug Code
Identifier(s): 0023-6145

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈